Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
作者信息
Shim Ju Hyun
机构信息
Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2020 Apr;26(2):183-184. doi: 10.3350/cmh.2020.0042. Epub 2020 Mar 12.
Abstract
摘要
相似文献
1
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?对于酒精性肝病或非酒精性脂肪性肝病患者，你应该提倡进行肝细胞癌监测吗？
Clin Mol Hepatol. 2020 Apr;26(2):183-184. doi: 10.3350/cmh.2020.0042. Epub 2020 Mar 12.
2
Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.影响脂肪性肝炎中肝细胞癌的代谢因素。
Liver Int. 2019 Mar;39(3):531-539. doi: 10.1111/liv.14002. Epub 2018 Dec 2.
3
[Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].[非酒精性脂肪性肝病与肝细胞癌 - 2016年]
Orv Hetil. 2016 Jun 19;157(25):987-94. doi: 10.1556/650.2016.30425.
4
Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.脂肪性肝病与肝细胞癌：病理医师的视角。
Adv Exp Med Biol. 2018;1032:55-69. doi: 10.1007/978-3-319-98788-0_4.
5
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.非酒精性脂肪性肝病相关肝细胞癌：日益受到关注。
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
6
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.非酒精性脂肪性肝病相关肝细胞癌的特征。
Lancet Gastroenterol Hepatol. 2016 Oct;1(2):156-164. doi: 10.1016/S2468-1253(16)30018-8. Epub 2016 Sep 8.
7
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
8
Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?酒精性和非酒精性脂肪性肝病中的肝细胞癌是同一种疾病吗？
Gastroenterology. 2016 Jun;150(8):1710-7. doi: 10.1053/j.gastro.2016.01.006. Epub 2016 Jan 16.
9
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.肝细胞癌与非酒精性脂肪性肝炎：现状
World J Gastroenterol. 2016 Feb 28;22(8):2494-502. doi: 10.3748/wjg.v22.i8.2494.
10
Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?肝细胞癌监测在欧洲环境中的应用。我们能从临床实践中学到什么？
Liver Int. 2015 Jul;35(7):1862-71. doi: 10.1111/liv.12764. Epub 2015 Jan 20.
引用本文的文献
1
Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease.代谢风险因素对酒精性和非酒精性脂肪性肝病患者肝脏和心脏结局的影响。
JHEP Rep. 2023 Mar 5;5(6):100721. doi: 10.1016/j.jhepr.2023.100721. eCollection 2023 Jun.
2
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea.韩国肝细胞癌患者新出现的年龄模式变化。
Clin Mol Hepatol. 2023 Jan;29(1):99-101. doi: 10.3350/cmh.2022.0321. Epub 2022 Oct 27.
3
Surveillance for hepatocellular carcinoma: It is time to move forward.肝细胞癌监测：是时候向前迈进了。
Clin Mol Hepatol. 2022 Oct;28(4):810-813. doi: 10.3350/cmh.2022.0257. Epub 2022 Sep 6.
4
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.二甲双胍和二氯乙酸通过抑制 mTOR 复合物 1 抑制肝癌细胞增殖。
Int J Mol Sci. 2021 Sep 17;22(18):10027. doi: 10.3390/ijms221810027.
5
Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study.血清肌生成抑制素预测酒精性肝硬化患者肝细胞癌风险：一项多中心研究
Cancers (Basel). 2020 Nov 12;12(11):3347. doi: 10.3390/cancers12113347.
6
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中肝细胞癌的监测
Diagnostics (Basel). 2020 Aug 10;10(8):579. doi: 10.3390/diagnostics10080579.
本文引用的文献
1
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新：非酒精性脂肪性肝病患者肝细胞癌的筛查和监测：专家综述。
Gastroenterology. 2020 May;158(6):1822-1830. doi: 10.1053/j.gastro.2019.12.053. Epub 2020 Jan 30.
2
Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.非酒精性脂肪性肝炎与酒精相关肝细胞癌的比较。
Clin Mol Hepatol. 2020 Apr;26(2):196-208. doi: 10.3350/cmh.2019.0012. Epub 2020 Jan 9.
3
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的肝细胞癌风险。
Gastroenterology. 2018 Dec;155(6):1828-1837.e2. doi: 10.1053/j.gastro.2018.08.024. Epub 2018 Aug 23.
4
Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.系统评价与荟萃分析：非酒精性脂肪性肝炎且无肝硬化与其他肝病相比发生肝细胞癌的风险。
Aliment Pharmacol Ther. 2018 Oct;48(7):696-703. doi: 10.1111/apt.14937. Epub 2018 Aug 22.
5
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.估算酒精性肝硬化患者肝细胞癌的发病率。
J Hepatol. 2018 Dec;69(6):1274-1283. doi: 10.1016/j.jhep.2018.07.022. Epub 2018 Aug 6.
6
Should Patients With NAFLD/NASH Be Surveyed for HCC?非酒精性脂肪性肝病/非酒精性脂肪性肝炎患者应筛查肝细胞癌吗？
Transplantation. 2019 Jan;103(1):39-44. doi: 10.1097/TP.0000000000002361.
7
Epidemiology of liver cancer in South Korea.韩国肝癌的流行病学。
Clin Mol Hepatol. 2018 Mar;24(1):1-9. doi: 10.3350/cmh.2017.0112. Epub 2017 Dec 18.
8
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.2015 年全球疾病负担研究：1990 年至 2015 年全球、区域和国家一级原发性肝癌及相关病因负担。
JAMA Oncol. 2017 Dec 1;3(12):1683-1691. doi: 10.1001/jamaoncol.2017.3055.
9
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
10
International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.1978 - 2007年肝癌发病率的国际趋势，总体及按组织学亚型划分的趋势
Int J Cancer. 2016 Oct 1;139(7):1534-45. doi: 10.1002/ijc.30211. Epub 2016 Jun 28.
Zotero 插件